Adage Capital Partners Gp, L.L.C. Mereo Biopharma Group PLC Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 9,715,013 shares of MREO stock, worth $37 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
9,715,013
Previous 11,791,310
17.61%
Holding current value
$37 Million
Previous $42.4 Million
5.94%
% of portfolio
0.07%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding MREO
# of Institutions
84Shares Held
107MCall Options Held
209KPut Options Held
479K-
Rubric Capital Management LP New York, NY15.3MShares$58.3 Million1.75% of portfolio
-
Janus Henderson Group PLC London, X012.3MShares$47 Million0.03% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.53MShares$36.3 Million1.33% of portfolio
-
Mangrove Partners New York, NY8.73MShares$33.3 Million4.66% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.71MShares$25.6 Million0.51% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $476M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...